Factbox: Countries weigh 'mix and match' COVID-19 vaccines

Sept 27 (Reuters) - A growing number of countries are looking at switching to different COVID-19 vaccines for second doses or booster shots after supply delays and safety concerns slowed their vaccination campaigns. read more

The World Health Organization (WHO) said on July 12 that the practice was a dangerous trend since there was little data about the health impact. Europe's drug regulator on July 14 made no definitive recommendations on switching vaccines. read more

The following countries are considering, or have decided to adopt, such an approach:


A British study is looking into the immune responses of children to mixed schedules of different vaccines. Officials said that while the recipients will be given a first dose of the Pfizer-BioNTech shot, advice about second doses will be provided at a later date, while more data is gathered. read more

Britain is preparing for a 'mix and match' COVID-19 vaccine booster programme, the Financial Times reported on September 10.


Cambodian Prime Minister Hun Sen said on Aug. 1 that a booster shot of AstraZeneca's (AZN.L) vaccine would be offered to people who had received two doses of shots from either Sinopharm or Sinovac (SVA.O), while a Sinovac booster should be given to Cambodians fully inoculated with the AstraZeneca shot. read more


Denmark's State Serum Institute, which deals with infectious diseases, said on Aug. 2 that combining AstraZeneca's vaccine with a second shot from either Pfizer-BioNTech (PFE.N) or Moderna (MRNA.O) provides "good protection". read more


Germany will offer booster shots of the Pfizer-BioNTech and Moderna vaccines from September to vulnerable individuals such as pensioners and people with weak immune systems, regardless of which vaccine they had previously received. read more


Russia's Direct Investment Fund (RDIF) said on September 27 that a small-scale clinical study combining the AstraZeneca and Sputnik Light shots had shown strong antibody growth in a majority of the study's participants. read more


Turkey is allowing people who have been inoculated with Sinovac's vaccine to receive an additional Pfizer (PFE.N) dose as it looks to ease travel to countries that have not approved the Chinese shot, Turkey's health ministry said on Aug. 16. read more


U.S. regulators authorised a third dose from either Pfizer-BioNTech or Moderna on Aug. 13 for people with compromised immune systems who are likely to have weaker protection from two-dose regimens. If a recipient's original shot is not available, they can be vaccinated with the other one. read more

Reporting by Federico Maccioni; Editing by David Clarke and Gareth Jones

Our Standards: The Thomson Reuters Trust Principles.